comp comp
anoth strong organ sale growth quarter stood us
upsid margin larg driven oper leverag upgrad pg share
april ground two separ relat topic sustain market-
lead organ sale growth could last year quarter flow-through
oper leverag stronger sale growth one quarter fiscal year
 comp comp acceler point sequenti two-year
stack compani also deliv oper margin fulli bp better wed
model bp varianc stem favor oper leverag
assum moder level seen past two quarter
expect compani deliv high end upgrad guidanc bp
oper leverag contribut bp oper margin expans despit
lower ep estim model ep
growth full year high end guidanc
date seen chang global competit landscap believ
compani guidanc emb signific flexibl need respond
pocket competit activ nine month sinc mani global hpc compani
gave guidanc includ step reinvest activ yet
mention yet see notabl chang competit landscap still wed
expect market becom bit competit next year exampl
unilev clear intent regain market share hair think
safe assum competit environ wet shave could intensifi ahead
edgewel acquisit harri babi privat label gain meaning
share said choos reinvest increment
mm pre-tax versu alreadi model would still abl deliv
midpoint guidanc ep growth would still consid peer lead
pg top pick despit move ytd vs still see upsid
pg quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight year market share
declin believ better posit today
final grow ahead market expect stock
comfort hold rel premium versu
 consum stapl given above-p sale
assum trade upsid case
ep
assum trade downsid ep
estim
lauren lieberman herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
unless otherwis indic price sourc refinitiv reflect close price relev trade market may last
avail price time public
